ArticleJournal of the American Chemical Society2016
Enantioselective Cu-Catalyzed Arylation of Secondary Phosphine Oxides with Diaryliodonium Salts toward the Synthesis of P-Chiral Phosphines.
Article in Journal of the American Chemical Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 211 citations in OpenAlex.
- Enantiodivergent Carbon-Phosphorus Bond Formation via Enzymatic Carbene Insertion.Journal of the American Chemical Society · 2026Article
- Article
- P-Chiral Organophosphorus Compounds: Synthesis, Mechanism, and Applications.Chemistry, an Asian journal · 2026Review
- Copper-Phosphido Catalysis: Enantioselective Addition of Phosphines to Cyclopropenes.Angewandte Chemie (International ed. in English) · 2023Article
- Catalytic enantioselective nucleophilic desymmetrization of phosphonate esters.Nature chemistry · 2023Article
- A Ni-catalyzed asymmetric C(sp)-P cross-coupling reaction for the synthesis of P-stereogenic alkynylphosphines.Chemical science · 2023Article
- Direct visible-light-induced synthesis of P-stereogenic phosphine oxides under air conditions.Chemical science · 2022Article
- Ni-catalyzed asymmetric hydrophosphinylation of conjugated enynes and mechanistic studies.Chemical science · 2022Article
- Enantioseparation ofThe Journal of organic chemistry · 2021Article
- Access toChemical science · 2021Article
- A chiroptical approach for the absolute stereochemical determination ofChemical science · 2020Article
- Access toChemical science · 2020Article
- Palladium-catalyzed asymmetric hydrophosphorylation of alkynes: facile access toChemical science · 2020Article
- Enantioselective synthesis ofChemical science · 2020Article
- Copper-catalyzedBeilstein journal of organic chemistry · 2020Article
- Access to P-chiral phosphine oxides by enantioselective allylic alkylation of bisphenols.Chemical science · 2019Article
- New Developments on the Hirao Reactions, Especially from "Green" Point of View.Current organic synthesis · 2019Article
- Tailored trisubstituted chiral CpChemical science · 2018Article
- Direct C-H functionalization of difluoroboron dipyrromethenes (BODIPYs) at β-position by iodonium salts.RSC advances · 2018Article
- DFT calculations on the mechanism of copper-catalysed tandem arylation-cyclisation reactions of alkynes and diaryliodonium salts.Beilstein journal of organic chemistry · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Catalytic synthesis of nonracemic P-chiral phosphine derivatives remains a significant challenge. Here we report Cu-catalyzed enantioselective arylation of secondary phosphine oxides with diaryliodonium salts for the synthesis of tertiary phosphine oxides with high enantiomeric excess. The new process is demonstrated on a wide range of substrates and leads to products that are well-established P-chiral catalysts and ligands.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.